Evidence map›Paper›PMID 36741401›Full record

ArticleFrontiers in immunology2022

Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection.

Marte Heimli, Siri Tennebø Flåm, Hanne Sagsveen Hjorthaug, Don Trinh, Michael Frisk, Karl-Andreas Dumont, Teodora Ribarska, Xavier Tekpli, Mario Saare, Benedicte Alexandra Lie

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Multimodal analysis definesbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Rediscovering the human thymus through cutting-edge technologies.The Journal of experimental medicine · 2024
    Review
  19. Article
  20. Zfp281 and Zfp148 control CD4Science immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Marte HeimliDepartment of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway.
Siri Tennebø FlåmDepartment of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway.
Hanne Sagsveen HjorthaugDepartment of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway.
Don TrinhDepartment of Pathology, Oslo University Hospital, Oslo, Norway.
Michael FriskInstitute for Experimental Medical Research, Oslo University Hospital, University of Oslo, Oslo, Norway.
Karl-Andreas DumontDepartment of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway.
Teodora RibarskaDepartment of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway.
Xavier TekpliDepartment of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway.
Mario SaareDepartment of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway.
Benedicte Alexandra LieDepartment of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway.
University of Oslo · NOOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To prevent autoimmunity, thymocytes expressing self-reactive T cell receptors (TCRs) are negatively selected, however, divergence into tolerogenic, agonist selected lineages represent an alternative fate. As thymocyte development, selection, and lineage choices are dependent on spatial context and cell-to-cell interactions, we have performed Cellular Indexing of Transcriptomes and Epitopes by sequencing (CITE-seq) and spatial transcriptomics on paediatric human thymu​​s. Thymocytes expressing markers of strong TCR signalling diverged from the conventional developmental trajectory prior to CD4

Indexed as

ThymocytesT-Lymphocyte SubsetsAutoimmunityChildHumansReceptors, Antigen, T-CellSignal TransductionReceptors, Antigen, T-Cellantigen-presenting cellsautoimmunityhuman thymusmulti-modalsingle-cell RNA sequencingspatial transcriptomicsT agonist selectionT cell development

Identifiers

PMID36741401
PMCPMC9895842
OpenAlexW4317627602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.